Senior Bioinformatician / PhD Candidate

SAGA Diagnostics

Lund University

Biography

I work as a Senior Bioinformatician at the cancer diagnostics company SAGA Diagnostics and am completing a PhD in cancer genomics at Lund University in Sweden.

My research focuses on the development of diagnostics based on tumor DNA/RNA deep sequencing (also known as next generation sequencing) to improve breast cancer treatment and survival. Most of my projects are embedded in the Sweden Cancerome Analysis Network–Breast (SCAN-B) study. Additionally I work on improving open source bioinformatics and reproducible research infrastructure by contributing to projects such as conda-forge, Bioconda, and Biopython.

Over the past 20 years I have contributed to a number of open source software projects, most notably the FreeBSD computer operating system. An overview can be found on OpenHub.

Interests

  • Bioinformatics
  • Cancer Biology and Diagnostics
  • Open Source Software
  • Software Engineering

Education

  • MSc in Bioinformatics

    Lund University

  • BSc in Scientific Programming

    Aachen University of Applied Sciences

Projects

SCAN-B MutationExplorer

A web-based application for exploring tumor somatic mutations.

RNA Sequencing for Breast Cancer Diagnostics

My PhD work in developing RNA sequencing-based diagnostic tools for breast cancer.

FreeBSD

I have been a developer with the FreeBSD operating system project since 2003. This page collates some related links.

Recent Publications

Quickly discover relevant content by filtering publications.

precisionFDA Truth Challenge V2: Calling variants from short- and long-reads in difficult-to-map regions

The mutational landscape of the SCAN-B real-world primary breast cancer transcriptome

Features of increased malignancy in eosinophilic clear cell renal cell carcinoma

A crowdsourced set of curated structural variants for the human genome

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment

Contact